Traders sold shares of CME Group Inc (NASDAQ:CME) on strength during trading hours on Thursday. $115.28 million flowed into the stock on the tick-up and $171.02 million flowed out of the stock on the tick-down, for a money net flow of $55.74 million out of the stock. Of all companies tracked, CME Group had the 0th highest net out-flow for the day. CME Group traded up $0.82 for the day and closed at $189.02

Several brokerages recently issued reports on CME. Berenberg Bank set a $184.00 price objective on CME Group and gave the stock a “hold” rating in a report on Thursday, September 20th. Zacks Investment Research raised CME Group from a “sell” rating to a “hold” rating in a report on Tuesday, September 18th. Citigroup began coverage on CME Group in a report on Tuesday, November 20th. They set a “buy” rating and a $220.00 price objective for the company. Wells Fargo & Co lifted their price objective on CME Group from $175.00 to $177.00 and gave the stock a “market perform” rating in a report on Friday, October 26th. Finally, Deutsche Bank reaffirmed a “buy” rating and set a $192.00 price objective (up from $185.00) on shares of CME Group in a report on Thursday, October 11th. Six research analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $194.13.

The firm has a market capitalization of $64.24 billion, a price-to-earnings ratio of 39.23, a price-to-earnings-growth ratio of 2.19 and a beta of 0.46. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.09 and a quick ratio of 1.09.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, October 25th. The financial services provider reported $1.45 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.42 by $0.03. CME Group had a return on equity of 9.18% and a net margin of 113.67%. The company had revenue of $904.20 million during the quarter, compared to analysts’ expectations of $910.50 million. On average, research analysts anticipate that CME Group Inc will post 6.66 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 27th. Stockholders of record on Monday, December 10th will be issued a $0.70 dividend. The ex-dividend date is Friday, December 7th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.50%. CME Group’s dividend payout ratio (DPR) is 58.70%.

In other news, Chairman Terrence A. Duffy sold 10,000 shares of the business’s stock in a transaction on Friday, November 23rd. The stock was sold at an average price of $188.80, for a total value of $1,888,000.00. Following the completion of the transaction, the chairman now directly owns 95,652 shares of the company’s stock, valued at $18,059,097.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Julie Winkler sold 5,847 shares of the business’s stock in a transaction on Friday, November 16th. The stock was sold at an average price of $195.01, for a total value of $1,140,223.47. Following the completion of the transaction, the insider now directly owns 24,255 shares of the company’s stock, valued at $4,729,967.55. The disclosure for this sale can be found here. Over the last three months, insiders sold 29,800 shares of company stock valued at $5,628,462. Insiders own 0.43% of the company’s stock.

Several large investors have recently made changes to their positions in CME. Cornerstone Wealth Management LLC purchased a new stake in shares of CME Group in the second quarter valued at $153,000. Dupont Capital Management Corp grew its position in shares of CME Group by 30.5% in the second quarter. Dupont Capital Management Corp now owns 3,326 shares of the financial services provider’s stock valued at $545,000 after purchasing an additional 777 shares during the period. First Trust Advisors LP grew its position in shares of CME Group by 140.9% in the second quarter. First Trust Advisors LP now owns 278,048 shares of the financial services provider’s stock valued at $45,578,000 after purchasing an additional 162,604 shares during the period. Jennison Associates LLC purchased a new stake in shares of CME Group in the second quarter valued at $1,058,000. Finally, Alps Advisors Inc. purchased a new stake in shares of CME Group in the second quarter valued at $1,640,000. 85.89% of the stock is owned by institutional investors and hedge funds.

WARNING: “Investors Sell CME Group (CME) on Strength (CME)” was originally reported by Marea Informative and is owned by of Marea Informative. If you are viewing this piece on another site, it was copied illegally and republished in violation of US & international copyright & trademark law. The correct version of this piece can be accessed at https://www.mareainformativa.com/news/2018/12/08/investors-sell-cme-group-cme-on-strength-cme.html.

About CME Group (NASDAQ:CME)

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Featured Article: Balanced Fund

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.